We believe that whether one smokes for purpose or for pleasure; health and happy experiences are important to us. We are boutique batch growers of artisan strains and our genetics have withstood the test of time as terpene rich and naturally resistant. We rely on environmental controls and biological solutions for pest and mold management then scientifically test for contaminants because everyone’s health matters. #BEHAPPY!
Shawn DeNae Wagenseller, Washington Bud Company CEO
Washington Bud Company
Sponsor (Vegetative)
Donor
Information Set
- No information available at this time
Observations
WSLCB - Listen and Learn Forum - Cannabinoid Regulation
(July 28, 2022) - Summary
A relatively quiet forum produced few remarks or questions on draft changes to cannabis ingredient and processing rules, which aimed to further regulate cannabinoids beyond THC.
WA SECTF - Work Group - Non-Violent Offense Policy and Home Grow - Public Meeting
(July 11, 2022) - Summary
- USA - Washington
- Washington State Legislative Task Force on Social Equity in Cannabis Non-Violent Offense Policy and Home Grow Work Group (WA SECTF - Work Group - Non-Violent Offense Policy and Home Grow)
Following introductions, members contemplated how to improve criminal history checks for social equity applicants and prepared to advise regulators to disregard drug offenses broadly.
WSLCB - Deliberative Dialogue - Cannabis Impairment
(June 21, 2022) - Summary
Panelists with experience in drug prevention and behavioral science couldn’t reach consensus on the question of what makes cannabinoids impairing during a final dialogue on the topic.
WSLCB - Deliberative Dialogue - Cannabis Impairment
(April 27, 2022) - Summary
Panelists from previous talks returned to field questions on identifying and regulating impairing cannabinoids, goals much more difficult to reach for cannabis than for alcohol.
DOH - Public Hearing - Medical Marijuana Consultant Certification
(February 22, 2022) - Summary
After DOH representatives provided a brief background, two patients, a medical consultant, and a consultant trainer offered feedback on proposed changes to consultant certification rules.
WA Senate WM - Committee Meeting
(March 5, 2022) - SB 5983 - Public Hearing
A last-minute hearing on a repackaged bill to regulate synthesized cannabinoids revealed shared public health concerns but testimony otherwise remained just as sharply divided.
WA House FIN - Committee Meeting
(February 22, 2022) - SB 5004 - Public Hearing
Testimony on a bill to exempt registered medical cannabis patients from the excise tax on DOH compliant products was supportive and elicited several questions from lawmakers.
WA Senate LAW - Committee Meeting
(February 8, 2022) - HB 1105 - Public Hearing
A bill to grant all medical cannabis patients protection from arrest received almost entirely positive testimony, along with complaints about homegrowing and cannabis scheduling policy.
WA House APP - Committee Meeting
(February 4, 2022) - HB 1668 - Public Hearing
Testimony on legislation to revise regulation of cannabinoids emphasized policy pitfalls versus prospective benefits, and hinted at fiscal fallout from litigious hemp industry interests.
WSLCB - Board Meeting
(February 2, 2022) - Quality Control - Public Hearing
After more than three years, rulemaking on pesticide testing still elicited criticism from many producers and processors, though a few stakeholders suggested enacting and moving on.